what is microdosing on tirzepatide Chart: A Monthly Dose Guide For Josie Patients Microdosing Tirzepatide and Semaglutide for

Retatrutide is an investigational compound that is not FDA-approved, and PlexusDx does not sell, distribute, or prescribe Retatrutide or any other investigational peptide in this category

Managing sleep and stress can restart progress within weeks

At a poster spotlight session at the 2025 San Antonio Breast Cancer Symposium , researchers presented their recent findings on the effects of GLP-1s on people with breast cancer

Nausea is the most common adverse effect , occurring in approximately 40-50% of patients taking GLP-1 receptor agonists, though rates vary by product and dose according to clinical trials (STEP trials for semaglutide